摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-bromo-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate | 841241-41-6

中文名称
——
中文别名
——
英文名称
ethyl 2-bromo-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate
英文别名
Ethyl 2-bromo-4-methylthieno[3,2-b]pyrrole-5-carboxylate
ethyl 2-bromo-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate化学式
CAS
841241-41-6
化学式
C10H10BrNO2S
mdl
——
分子量
288.165
InChiKey
OMWSOJSIJCXPPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    59.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 2-bromo-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate 在 sodium azide 、 copper(l) chloride 作用下, 以 二甲基亚砜乙腈 为溶剂, 反应 1.1h, 生成
    参考文献:
    名称:
    Indirect C–H Azidation of Heterocycles via Copper-Catalyzed Regioselective Fragmentation of Unsymmetrical λ3-Iodanes
    摘要:
    A C-H bond of electron-rich heterocycles is transformed into a C-N bond in a reaction sequence comprising the formation of heteroaryl(phenyl)iodonium azides and their in situ regioselective fragmentation to heteroaryl azides. A Cu(I) catalyst ensures complete regiocontrol in the fragmentation step and catalyzes the subsequent 1,3-dipolar cycloaddition of the formed azido heterocycles with acetylenes. The heteroaryl azides can also be conveniently reduced to heteroarylamines by aqueous ammonium sulfide. The overall C-H to C-N transformation is a mild and operationally simple one-pot sequential multistep process.
    DOI:
    10.1021/ja305574k
  • 作为产物:
    参考文献:
    名称:
    Thieno [3,2 - b ]吡咯-5-羧酰胺是组蛋白赖氨酸脱甲基酶KDM1A / LSD1的新型可逆抑制剂。第1部分:高通量筛选和初步探索
    摘要:
    赖氨酸特异性脱甲基酶1 KDM1A(LSD1)调节组蛋白甲基化,并日益被认为是肿瘤学中潜在的治疗靶标。我们报告了使用时间分辨荧光共振能量转移(TR-FRET)技术在KDM1A / CoREST上进行的高通量筛选活动,以鉴定可逆抑制剂。筛选导致115个结果,我们确定了它们的生化IC 50,从而确定了四个化学系列。经过数据分析,我们确定了N-苯基-4 H-噻吩并[3,2- b ]吡咯-5-羧酰胺的化学系列的优先级,为此,我们获得了最有力的X射线结构(化合物19,IC 50= 2.9μM)与酶复合。该化学类别的最初扩展,包括修饰核心结构和修饰苯甲酰胺部分,都指向负责与酶相互作用的部分的定义。初步优化产生了化合物90,该化合物具有亚微摩尔IC 50(0.162μM)抑制酶,能够抑制细胞中的靶标。
    DOI:
    10.1021/acs.jmedchem.6b01018
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Intermolecular C–H Amination of (Hetero)arenes via Transient Unsymmetrical λ<sup>3</sup>-Iodanes
    作者:Igors Sokolovs、Dmitrijs Lubriks、Edgars Suna
    DOI:10.1021/ja502174d
    日期:2014.5.14
    A one-pot two-step method for intermolecular C-H amination of electron-rich heteroarenes and arenes has been developed. The approach is based on a room-temperature copper-catalyzed regioselective reaction of the in situ formed unsymmetrical (hetero)aryl-λ(3)-iodanes with a wide range of primary and secondary aliphatic amines and anilines.
    已经开发了一种用于富电子杂芳烃和芳烃的分子间 CH 胺化的一锅两步法。该方法基于室温铜催化的区域选择性反应,即原位形成的不对称(杂)芳基-λ(3)-碘烷与多种脂肪族伯胺和仲胺和苯胺。
  • Synthesis of Oxidized Thienopyrroles using HOF·CH<sub>3</sub>CN
    作者:Neta Shefer、Shlomo Rozen
    DOI:10.1021/jo200534p
    日期:2011.6.3
    An efficient transformation of the sulfur atoms to the sulfonyl group in a range of thienopyrroles was achieved by using the HOF·CH3CN complex. Mild conditions, high yields, and easy purification are the main features of this novel route. Most new materials exhibit considerable red-shift absorptions in the UV/visible range relative to the parent compounds.
    通过使用HOF·CH 3 CN络合物,可以在一定范围的噻吩并吡咯中将硫原子有效转化为磺酰基。温和的条件,高收率和易于纯化是该新途径的主要特征。相对于母体化合物,大多数新材料在UV /可见光范围内均显示出可观的红移吸收。
  • Indirect C–H Azidation of Heterocycles via Copper-Catalyzed Regioselective Fragmentation of Unsymmetrical λ<sup>3</sup>-Iodanes
    作者:Dmitrijs Lubriks、Igors Sokolovs、Edgars Suna
    DOI:10.1021/ja305574k
    日期:2012.9.19
    A C-H bond of electron-rich heterocycles is transformed into a C-N bond in a reaction sequence comprising the formation of heteroaryl(phenyl)iodonium azides and their in situ regioselective fragmentation to heteroaryl azides. A Cu(I) catalyst ensures complete regiocontrol in the fragmentation step and catalyzes the subsequent 1,3-dipolar cycloaddition of the formed azido heterocycles with acetylenes. The heteroaryl azides can also be conveniently reduced to heteroarylamines by aqueous ammonium sulfide. The overall C-H to C-N transformation is a mild and operationally simple one-pot sequential multistep process.
  • Thieno[3,2-<i>b</i>]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration
    作者:Luca Sartori、Ciro Mercurio、Federica Amigoni、Anna Cappa、Giovanni Fagá、Raimondo Fattori、Elena Legnaghi、Giuseppe Ciossani、Andrea Mattevi、Giuseppe Meroni、Loris Moretti、Valentina Cecatiello、Sebastiano Pasqualato、Alessia Romussi、Florian Thaler、Paolo Trifiró、Manuela Villa、Stefania Vultaggio、Oronza A. Botrugno、Paola Dessanti、Saverio Minucci、Elisa Zagarrí、Daniele Carettoni、Lucia Iuzzolino、Mario Varasi、Paola Vianello
    DOI:10.1021/acs.jmedchem.6b01018
    日期:2017.3.9
    increasingly recognized as a potential therapeutic target in oncology. We report on a high-throughput screening campaign performed on KDM1A/CoREST, using a time-resolved fluorescence resonance energy transfer (TR-FRET) technology, to identify reversible inhibitors. The screening led to 115 hits for which we determined biochemical IC50, thus identifying four chemical series. After data analysis, we have
    赖氨酸特异性脱甲基酶1 KDM1A(LSD1)调节组蛋白甲基化,并日益被认为是肿瘤学中潜在的治疗靶标。我们报告了使用时间分辨荧光共振能量转移(TR-FRET)技术在KDM1A / CoREST上进行的高通量筛选活动,以鉴定可逆抑制剂。筛选导致115个结果,我们确定了它们的生化IC 50,从而确定了四个化学系列。经过数据分析,我们确定了N-苯基-4 H-噻吩并[3,2- b ]吡咯-5-羧酰胺的化学系列的优先级,为此,我们获得了最有力的X射线结构(化合物19,IC 50= 2.9μM)与酶复合。该化学类别的最初扩展,包括修饰核心结构和修饰苯甲酰胺部分,都指向负责与酶相互作用的部分的定义。初步优化产生了化合物90,该化合物具有亚微摩尔IC 50(0.162μM)抑制酶,能够抑制细胞中的靶标。
查看更多

同类化合物

N-甲基-n-[(4-甲基-4H-噻吩并[3,2-b]吡咯-5-基)甲基]胺盐酸盐 6H-噻吩并[2,3-b]吡咯-5-羧酸甲酯 6H-噻吩并[2,3-b]吡咯-5-羧酸乙酯 6H-噻吩并[2,3-b]吡咯-5-羧酸 6-[(3-氨基苯基)甲基]-4,6-二氢-4-甲基-2-(甲基亚磺酰)-5H-噻吩并[2',3':4,5]吡咯并[2,3-D]哒嗪-5-酮 4H-噻唑[3,2-B]吡咯-5-甲酸 4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 4H-噻吩并[3,2-B]吡咯-5-甲酰肼 4H-噻吩并[3,2-B]吡咯-5-甲酰氯 4H-噻吩并[3,2-B]吡咯-2-羧酸 4H-噻吩[3,2-b]吡咯-5-羧酸乙酯 4H-Dithieno[3,2-b:2',3'-d]吡咯,4-(1-辛基壬基)- 4-辛基-4H-二噻吩并[3,2-b:2,3-d]吡咯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 4-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸 4-甲基-4H-噻[3,2-B]吡咯-5-甲醛 4-R-4H-二噻吩并[3,2-b:2',3'-d]吡咯 3-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 3-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 3-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸 3-溴-4H-噻吩并[3,2-B]吡咯-5-羧酸甲酯 3-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-甲酰基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-甲基-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-溴-6-甲酰基-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-溴-6-甲酰基-4-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2-溴-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-溴-4,6-二氢-4-甲基-5H-噻吩并[2,3:4,5]吡咯并[2,3-d]吡嗪-5-酮 2-氯-6H-噻吩并[2,3-b]吡咯-5-羧酸乙酯 2-氯-6H-噻吩并[2,3-B]吡咯-5-羧酸甲酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸甲酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸乙酯 2-氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 2-氯-3-甲基-4H-噻吩并[3,2-B]吡咯-5-羧酸乙酯 2,6-二溴-4-正辛基二噻吩并[3,2-b:2',3'-d]吡咯 2,6-二溴-4-(2-乙基己基)-4H-二噻吩并[3,2-b:2,3-d]吡咯 2,3-二氯-4H-噻吩并[3,2-b]吡咯-5-羧酸 (4-甲基-4H-噻吩并[3,2-b]吡咯-5-基)甲醇 (4-(叔丁氧基羰基)-2-氯-4H-噻吩并[3,2-B]吡咯-5-基)硼酸 3-bromo-2-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylic acid methyl ester 5-thiophen-3-yl-thieno[3,2-b]pyrrole-4-carboxylic acid tert-butyl ester tert-butyl 5-butyl-4H-thieno[3,2-b]pyrrole-4-carboxylate tert-butyl 4H-thieno[3,2-b]pyrrole-4-carboxylate 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbohydrazide (4-methyl-piperazin-1-yl)-(3-methyl-4H-thieno[3,2-b]pyrrol-5-yl)-methanone 5-methyl-4H-thieno[3,2-b]pyrrole 4-hexyl-2,6-bis(thiophen-2-ylethynyl)-4H-dithieno[3,2-b;2′,3′-d]pyrrole 4-(3-chlorobenzyl)-2,6-bis-phenylethynylthieno[3,2-b]pyrrole-5-carboxylic acid (2-methoxyethyl)amide